France· FR:62978998
LYMPHOSEEK 50 microgrammes, trousse pour préparation radiopharmaceutique
A medicinal product containing tilmanocept, registered in France by NAVIDEA BIOPHARMACEUTICALS EUROPE (IRLANDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TILMANOCEPT
- Manufacturer
- NAVIDEA BIOPHARMACEUTICALS EUROPE (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550458611 flacons en verre de 50 microgrammes
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tilmanocept in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLymphoseek 50 µgNavidea Biopharmaceuticals Europe
- SpainLYMPHOSEEK 50 MICROGRAMOS EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICANavidea Biopharmaceuticals Europe Limited
- FinlandLymphoseekNavidea Biopharmaceuticals Europe Ltd.
- United KingdomLymphoseek 50microgram kit for radiopharmaceutical preparationNorgine Pharmaceuticals Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f950d36b-aee1-4ee8-a006-c211223a45cb GET /v1/drugs/f950d36b-aee1-4ee8-a006-c211223a45cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62978998",
"date_amm": "2014-11-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/955",
"substance": "TILMANOCEPT",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "trousse pour préparation radiopharmaceutique",
"voies_administration": "intradermique;intratumorale;péritumorale;sous-cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about tilmanocept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.